Skip to main content

beta This is a new site, your feedback will help us to improve it.


National Patient Safety Alert – NatPSA/2022/004/MHRA

Published on 26 May 2022

From: Health Facilities Scotland

NovoRapid PumpCart in the Roche Accu-Chek Insight insulin pump: risk of insulin leakage causing hyperglycaemia and diabetic ketoacidosis.



The MHRA continues to receive serious reports of harm associated with insulin leakage for the NovoRapid PumpCart prefilled insulin cartridge in the Accu-Chek Insight Insulin pump. In some patients, there were serious consequences arising from inadequate supply of insulin, including diabetic ketoacidosis (DKA).

Check you’ve received our safety alerts - NatPSAs